Cart
sales@molnova.com
Anle138b
CAS No. 882697-00-9
Anle138b( —— )
Catalog No. M20225 CAS No. 882697-00-9
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 34 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 116 | In Stock |
|
| 100MG | 189 | In Stock |
|
| 200MG | 275 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnle138b
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
-
DescriptionAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
-
In Vitro——
-
In VivoAnimal Model:Two‐month‐old PLP‐hαSyn miceDosage:0.6 and 2 g/kg Administration:Oral Result:Prevented motor deficits and neurodegeneration in the PLP‐hαSyn mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number882697-00-9
-
Formula Weight343.17
-
Molecular FormulaC16H11BrN2O2?
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL?(145.70 mM)
-
SMILESC1OC2=C(O1)C=C(C=C2)C3=CC(=NN3)C4=CC(=CC=C4)Br
-
Chemical Name5-(13-Benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wagner J et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol. 2013 Jun;125(6):795-813.
molnova catalog
related products
-
Papain Inhibitor
Papain inhibitor (Glycylglycyl-L-tyrosyl-L-arginine) acts as an effective competitive inhibitor to papain, with a Ki of 9 μM at pH 6.2.
-
Obtustatin
Highly potent integrin α1β1 inhibitor (IC50 = 0.8 nM for α1β1 binding to type IV collagen). Selective for α1β1 over α2β1, αIIbβ3, αvβ3, α4β1, α5β6, α9β1 and α4β7. Inhibits FGF2-stimulated angiogenesis in the chicken chorioallantoic model. Displays antitumor efficacy in a synergistic mouse model of Lewis lung carcinoma; blocks human melanoma growth in nude mice.
-
N-Benzylpalmitamide
N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.
